101.66
price up icon0.97%   0.98
pre-market  プレマーケット:  100.62   -1.04   -1.02%
loading
前日終値:
$100.68
開ける:
$100.7
24時間の取引高:
14.37M
Relative Volume:
1.06
時価総額:
$177.07B
収益:
$46.59B
当期純損益:
$5.41B
株価収益率:
32.86
EPS:
3.0938
ネットキャッシュフロー:
$7.38B
1週間 パフォーマンス:
+10.37%
1か月 パフォーマンス:
+14.99%
6か月 パフォーマンス:
-16.08%
1年 パフォーマンス:
-17.80%
1日の値動き範囲:
Value
$100.03
$102.46
1週間の範囲:
Value
$87.64
$102.46
52週間の値動き範囲:
Value
$81.97
$137.49

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1089)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
115,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-07-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABT icon
ABT
Abbott Laboratories
101.66 177.07B 46.59B 5.41B 7.38B 3.0938
SYK icon
SYK
Stryker Corp
319.14 122.35B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
83.29 106.61B 36.36B 4.84B 5.43B 3.7261
BSX icon
BSX
Boston Scientific Corp
43.77 65.06B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
85.00 48.94B 6.30B 1.07B 1.09B 1.8406

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-22 ダウングレード Daiwa Securities Outperform → Neutral
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Jul 20, 2026

Lobbying Update: $1,150,000 of ABBOTT LABORATORIES lobbying was just disclosed - Quiver Quantitative

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen - Ad-hoc-news.de

Jul 20, 2026
pulisher
Jul 20, 2026

Craneware, Abbott Probe Separate Health Data Theft Incidents - BankInfoSecurity

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories (NYSE:ABT) Faces A Major Medical Device Growth Test - Kalkine Media

Jul 20, 2026
pulisher
Jul 20, 2026

ShinyHunters hit medial giant Abbott, disrupting cancer drug research and more - Yahoo Tech

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Investigating Cyberattack Claims From Two Threat Actors - The HIPAA Journal

Jul 20, 2026
pulisher
Jul 20, 2026

Healthcare giant Abbott probes two cyber incidents amid extortion claims - Malwarebytes

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories investigates 2 separate cyber incidents - SC Media

Jul 20, 2026
pulisher
Jul 20, 2026

Fairlife dairy cyberattack, ACR Stealer surge, Abbott Labs incidents - LinkedIn

Jul 20, 2026
pulisher
Jul 20, 2026

Benchmark reiterates Buy on Abbott Labs stock, cites guidance raise - Investing.com

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories stock trades steady as diagnostics and medical devices support growth - Ad-hoc-news.de

Jul 20, 2026
pulisher
Jul 20, 2026

Cybersecurity News: Fairlife dairy cyberattack, ACR Stealer surge, Abbott Labs incidents - CISO Series

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Laboratories Cybersecurity Breach Analysis: ShinyHunters Attack on Exact Sciences Systems and ShadowByt3$ LabCentral Portal Incident - Rescana

Jul 20, 2026
pulisher
Jul 20, 2026

Abbott Investigates Two Separate Cyber Incidents, Says No Operations Affected - Insurance Journal

Jul 20, 2026
pulisher
Jul 18, 2026

Abbott Laboratories stock holds firm as diagnostics and medical devices support earnings - ad-hoc-news.de

Jul 18, 2026
pulisher
Jul 18, 2026

Medical giant Abbott investigates two cyber incidents as ShinyHunters claims breach - Cybernews

Jul 18, 2026
pulisher
Jul 18, 2026

This Dividend ETF Yields 3.2% and Is Beating the Nasdaq-100 This Year - The Motley Fool

Jul 18, 2026
pulisher
Jul 18, 2026

Abbott Laboratories (ABT) Stock Faces Margin Squeeze As Net Profit Slide Tests Growth Narrative - simplywall.st

Jul 18, 2026
pulisher
Jul 17, 2026

Abbott Stock: Bear Trap Over, With Richer Return Prospects (NYSE:ABT) - Seeking Alpha

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Just Showed Its Growth Engine Has More Than One Cylinder - Trefis

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott investigates two separate cyber incidents, says no operations affected By Reuters - Investing.com

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott investigates two cyber intrusions targeting cancer diagnostics and LabCentral portal - Межа. Новини України.

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott investigates two separate cyber incidents, says no operations affected - Reuters

Jul 17, 2026
pulisher
Jul 17, 2026

Keysight Invalidates IRS Rule On GILTI, Abbott Says - Law360

Jul 17, 2026
pulisher
Jul 17, 2026

US companies face rise in cyber attacks - Reuters

Jul 17, 2026
pulisher
Jul 17, 2026

Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott probes two cyber incidents amid extortion claims - BleepingComputer

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott discloses cyberattack on cancer diagnostics business - MedTech Dive

Jul 17, 2026
pulisher
Jul 17, 2026

ABT Reiterated by Piper Sandler -- Price Target Raised to $118 - GuruFocus

Jul 17, 2026
pulisher
Jul 17, 2026

Can Abbott Laboratories (NYSE:ABT) Extend Its Dividend Strength? - Kalkine Media

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories Stock Surges 11% as Company Lifts Full Year Profit Guidance - TIKR.com

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories Stock (ABT) Moved Up by 3.03% on Jul 17: Drivers Behind the Movement - TradingKey

Jul 17, 2026
pulisher
Jul 17, 2026

ABT Q2 Earnings Call Flags Stronger Second-Half Setup - The Globe and Mail

Jul 17, 2026
pulisher
Jul 17, 2026

These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results - Benzinga

Jul 17, 2026
pulisher
Jul 17, 2026

Benchmark reiterates Buy on Abbott Labs stock, keeps $120 target - Investing.com

Jul 17, 2026
pulisher
Jul 17, 2026

Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Can Abbott Stock Deliver on Its Second-Half Growth Promise? - Trefis

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories stock could rise 40%+ by 20... - Pluang

Jul 17, 2026
pulisher
Jul 17, 2026

JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating - marketscreener.com

Jul 17, 2026
pulisher
Jul 17, 2026

Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating - marketscreener.com

Jul 17, 2026
pulisher
Jul 17, 2026

Abbott Laboratories: Pick Up This Dividend King Deal Now - Seeking Alpha

Jul 17, 2026
pulisher
Jul 17, 2026

Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation - NAI500

Jul 17, 2026
pulisher
Jul 17, 2026

What Helped Abbott Laboratories (NYSE:ABT) Raise Full-Year Outlook? - Kalkine Media

Jul 17, 2026
pulisher
Jul 16, 2026

Abbott Laboratories (ABT) Could Be 15% Undervalued On Raised 2026 Earnings Outlook - simplywall.st

Jul 16, 2026
pulisher
Jul 16, 2026

Why Abbott Stock Jumped Today - The Motley Fool

Jul 16, 2026
pulisher
Jul 16, 2026

Abbott Laboratories Earnings Call Signals Broad-Based Momentum - TipRanks

Jul 16, 2026
pulisher
Jul 16, 2026

ABT: Abbott Laboratories Exceeds Revenue and EPS Expectations, R - GuruFocus

Jul 16, 2026
pulisher
Jul 16, 2026

Abbott Is On Deck to Launch Several New Devices - Morningstar

Jul 16, 2026
pulisher
Jul 16, 2026

ABT: Abbott Laboratories Exceeds Expectations and Raises Profit Outlook - GuruFocus

Jul 16, 2026
pulisher
Jul 16, 2026

Abbott Laboratories’s Stock Price Soars to $98.83, Enjoying a Robust 10.71% Uptick - Smartkarma

Jul 16, 2026
pulisher
Jul 16, 2026

BTIG raises Abbott Labs stock price target to $134 on Q2 strength - Investing.com

Jul 16, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
SYK SYK
$319.14
price down icon 0.23%
MDT MDT
$83.29
price up icon 0.11%
BSX BSX
$43.77
price down icon 0.59%
EW EW
$85.00
price down icon 0.85%
$75.69
price down icon 1.25%
大文字化:     |  ボリューム (24 時間):